Occident has led a CHF 5.1m round for therapeutic blood purification technology developer Hemotune, with participation from South Korea-based Greencross Medical Science Corp (GCMS) and the Zürcher Kantonalbank.
Occident leads CHF 5.1m series-A for Hemotune
Most Popular
